As Cvs Health (CVS) Share Value Declined, Holder Ballentine Partners Trimmed Its Holding by $311,445; Caisse De Depot Et Placement Du Quebec Has Increased Position in Visa (V)

January 19, 2018 - By Louis Casey

Ballentine Partners Llc decreased its stake in Cvs Health Corp (CVS) by 30.42% based on its latest 2017Q3 regulatory filing with the SEC. Ballentine Partners Llc sold 3,845 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 8,795 shares of the medical and nursing services company at the end of 2017Q3, valued at $716,000, down from 12,640 at the end of the previous reported quarter. Ballentine Partners Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $80.43 billion market cap company. The stock increased 0.05% or $0.04 during the last trading session, reaching $79.39. About 2.63M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 19, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Caisse De Depot Et Placement Du Quebec increased its stake in Visa Inc (V) by 17.45% based on its latest 2017Q3 regulatory filing with the SEC. Caisse De Depot Et Placement Du Quebec bought 6,000 shares as the company’s stock rose 5.74% with the market. The institutional investor held 40,392 shares of the business services company at the end of 2017Q3, valued at $4.27M, up from 34,392 at the end of the previous reported quarter. Caisse De Depot Et Placement Du Quebec who had been investing in Visa Inc for a number of months, seems to be bullish on the $276.64 billion market cap company. The stock decreased 0.84% or $1.04 during the last trading session, reaching $122.07. About 3.42 million shares traded. Visa Inc. (NYSE:V) has risen 20.29% since January 19, 2017 and is uptrending. It has outperformed by 3.59% the S&P500.

Since August 16, 2017, it had 0 insider buys, and 7 sales for $58.32 million activity. $20.03M worth of stock was sold by MERLO LARRY J on Wednesday, August 23. 39,340 shares valued at $3.22 million were sold by Foulkes Helena on Friday, September 15. $199,050 worth of stock was sold by SWIFT RICHARD J on Wednesday, August 16. 237,078 shares were sold by Denton David M, worth $18.88M. Another trade for 85,743 shares valued at $7.13 million was sold by Roberts Jonathan C.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 earnings per share, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92 billion for 10.45 P/E if the $1.90 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 66 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Robert W. Baird on Friday, January 22. The firm has “Hold” rating given on Monday, December 12 by Jefferies. The firm has “Hold” rating given on Wednesday, August 16 by Jefferies. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, August 5. The stock has “Neutral” rating by Citigroup on Monday, November 13. On Friday, June 9 the stock rating was maintained by Jefferies with “Hold”. The stock has “Buy” rating by Evercore on Wednesday, August 19. The company was upgraded on Thursday, January 4 by Raymond James. S&P Research maintained the stock with “Strong Buy” rating in Monday, November 2 report. On Tuesday, June 13 the stock rating was maintained by Cowen & Co with “Buy”.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It is negative, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Punch Investment Inc owns 55,315 shares. Cetera Advsrs Ltd Liability Co owns 18,692 shares. Northeast Inv Management has invested 2.11% of its portfolio in CVS Health Corporation (NYSE:CVS). Carroll Assocs holds 6,297 shares or 0.06% of its portfolio. Westwood, Texas-based fund reported 1.53 million shares. Eastern National Bank & Trust accumulated 194,810 shares or 1.12% of the stock. Goodman Fincl has 58,629 shares. Gru invested in 0.14% or 491,091 shares. Frontier Inv Management Communication reported 245,006 shares stake. Commercial Bank Of Nova Scotia Trust Co holds 0.39% of its portfolio in CVS Health Corporation (NYSE:CVS) for 45,360 shares. Loomis Sayles Limited Partnership reported 0.05% stake. Paradigm Advisors Limited Liability owns 11,473 shares. Wellington Mngmt Grp Llp accumulated 16.97M shares. Psagot House Ltd reported 56,601 shares. Umb Comml Bank N A Mo, Missouri-based fund reported 129,078 shares.

Ballentine Partners Llc, which manages about $4.78 billion and $1.81 billion US Long portfolio, upped its stake in Spdr S&P Midcap 400 Etf Tr (MDY) by 963 shares to 13,730 shares, valued at $4.48M in 2017Q3, according to the filing. It also increased its holding in Targa Res Corp (NYSE:TRGP) by 8,620 shares in the quarter, for a total of 22,098 shares, and has risen its stake in Forrester Resh Inc (NASDAQ:FORR).

Investors sentiment decreased to 1 in 2017 Q3. Its down 0.13, from 1.13 in 2017Q2. It dived, as 48 investors sold V shares while 617 reduced holdings. 142 funds opened positions while 524 raised stakes. 1.64 billion shares or 1.45% less from 1.66 billion shares in 2017Q2 were reported. Wealthcare Cap Management Ltd Liability Corp holds 0% in Visa Inc. (NYSE:V) or 12 shares. Amer Insur Com Tx holds 0.42% of its portfolio in Visa Inc. (NYSE:V) for 75,698 shares. Atlanta Capital Management L L C reported 1.85M shares. Fundsmith Llp has 5.22 million shares for 5.28% of their portfolio. Ipswich Mngmt Inc reported 44,799 shares stake. Staley Advisers holds 1,989 shares or 0.02% of its portfolio. Mckinley Carter Wealth Inc owns 4,018 shares or 0.16% of their US portfolio. Psagot Invest House Ltd holds 0.12% of its portfolio in Visa Inc. (NYSE:V) for 26,410 shares. Legal And General Group Inc Public Limited Com holds 0.72% or 9.11 million shares. Etrade Capital Ltd Liability Co has 0.09% invested in Visa Inc. (NYSE:V). Piedmont Limited Liability Company holds 0.95% of its portfolio in Visa Inc. (NYSE:V) for 425,671 shares. 272 were accumulated by Hoertkorn Richard Charles. Logan Mngmt owns 19,942 shares or 0.15% of their US portfolio. Gofen Glossberg Ltd Il reported 6,320 shares stake. Boston Common Asset Mngmt holds 84,365 shares or 1.11% of its portfolio.

Caisse De Depot Et Placement Du Quebec, which manages about $43.34 billion US Long portfolio, decreased its stake in New Oriental Education & Technology Group Inc (NYSE:EDU) by 5,000 shares to 218,206 shares, valued at $19.34M in 2017Q3, according to the filing. It also reduced its holding in General Motors Co (NYSE:GM) by 1.07 million shares in the quarter, leaving it with 2.33M shares, and cut its stake in Alibaba Group Holding Ltd (NYSE:BABA).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts